Money Concepts Capital’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
– Sell
-6,058
Closed -$849K – 521
2025
Q3
$849K Buy
6,058
+29
+0.5% +$3.92K 0.05% 265
2025
Q2
$757K Buy
6,029
+54
+0.9% +$6.73K 0.05% 271
2025
Q1
$818K Sell
5,975
-3,203
-35% -$458K 0.06% 243
2024
Q4
$1.4M Buy
9,178
+63
+0.7% +$10.6K 0.1% 176
2024
Q3
$1.77M Buy
9,115
+231
+3% +$48.3K 0.13% 152
2024
Q2
$2.06M Sell
8,884
-211
-2% -$45.9K 0.17% 135
2024
Q1
$1.96M Sell
9,095
-119
-1% -$27.9K 0.18% 146
2023
Q4
$2.38M Sell
9,214
-232
-2% -$57K 0.22% 118
2023
Q3
$2.43M Buy
9,446
+373
+4% +$99.8K 0.25% 113
2023
Q2
$2.58M Buy
9,073
+272
+3% +$81K 0.26% 112
2023
Q1
$2.45M Sell
8,801
-2,651
-23% -$734K 0.14% 136
2022
Q4
$3.17M Buy
11,452
+761
+7% +$215K 0.14% 138
2022
Q3
$2.85M Sell
10,691
-423
-4% -$89.8K 0.17% 118
2022
Q2
$2.34M Sell
11,114
-1,197
-10% -$245K 0.21% 113
2022
Q1
$2.59M Buy
12,311
+2,594
+27% +$564K 0.15% 162
2021
Q4
$2.33M Buy
+9,717
New +$2.5M 0.2% 119
2021
Q1
$2.34M Buy
8,374
+4,413
+111% +$1.19M 0.19% 122
2020
Q4
$970K Buy
+3,961
New +$1.02M 0.09% 191

Other funds holding BIIB

Money Concepts Capital's BIIB Position: Q4 2025 in Review

Money Concepts Capital sold out of Biogen (BIIB) in Q4 2025, closing a stake of 6,058 shares — an estimated $849K sold.

Money Concepts Capital first reported a position in BIIB in Q4 2020 and held it in 18 quarters. The position peaked at $3.17M in Q4 2022. 1,000 funds tracked by Wall St. Rank hold BIIB as of Q4 2025.

  • Money Concepts Capital reported no remaining Biogen position as of Q4 2025 after selling out during the quarter.
  • Money Concepts Capital sold 6,058 Biogen shares in Q4 2025, an estimated $849K.
  • Money Concepts Capital first reported a position in Biogen in Q4 2020 and held it in 18 quarters.
  • Money Concepts Capital's Biogen position peaked at $3.17M in Q4 2022.
  • 1,000 funds tracked by Wall St. Rank held Biogen as of Q4 2025.

Based on Money Concepts Capital's 13F filing for Q4 2025, filed 4 Feb 2026.